These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Managing psychotic symptoms when the diagnosis is unclear. Ninan PT; Shelton S Hosp Community Psychiatry; 1993 Feb; 44(2):107-8. PubMed ID: 8432491 [No Abstract] [Full Text] [Related]
43. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Hoehn-Saric R; Pearlson GD; Harris GJ; Machlin SR; Camargo EE Am J Psychiatry; 1991 Sep; 148(9):1243-5. PubMed ID: 1883007 [TBL] [Abstract][Full Text] [Related]
44. Fluoxetine and memory impairment. Bradley SJ; Kulik L J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1078-9. PubMed ID: 8407756 [No Abstract] [Full Text] [Related]
45. [5 years' experience with a new tranquilizer lexotanil (ro 5-3350) in ambulatory patients in a psychiatric practice (author's transl)]. Laffranchini S Ther Umsch; 1975 Nov; 32(11):741-4. PubMed ID: 820015 [No Abstract] [Full Text] [Related]
46. Fluoxetine in obsessive compulsive disorder in adolescents. Bouvard M; Dugas M Int Clin Psychopharmacol; 1993; 8(4):307-10. PubMed ID: 8277152 [No Abstract] [Full Text] [Related]
47. Extending indications for long-term pharmacotherapy: opportunities and challenges. Kane JM Am J Psychiatry; 2002 Jan; 159(1):1-2. PubMed ID: 11772679 [No Abstract] [Full Text] [Related]
48. A case of fluoxetine-responsive psychogenic polydipsia: a variant of obsessive-compulsive disorder? Deas-Nesmith D; Brewerton TD J Nerv Ment Dis; 1992 May; 180(5):338-9. PubMed ID: 1583478 [No Abstract] [Full Text] [Related]
49. Obsessive-compulsive disorder in HIV disease. Response to fluoxetine. McDaniel JS; Johnson KM Psychosomatics; 1995; 36(2):147-50. PubMed ID: 7724717 [No Abstract] [Full Text] [Related]
50. Antiobsessive effect of fluoxetine. Fontaine R; Chouinard G Am J Psychiatry; 1985 Aug; 142(8):989. PubMed ID: 3875293 [No Abstract] [Full Text] [Related]
51. Familial obsessive-compulsive disorder presenting as pathological jealousy successfully treated with fluoxetine. Wright S Arch Gen Psychiatry; 1994 May; 51(5):430-1. PubMed ID: 8179468 [No Abstract] [Full Text] [Related]
54. Hair loss associated with fluoxetine treatment. Ananth J; Elmishaugh A Can J Psychiatry; 1991 Oct; 36(8):621. PubMed ID: 1742721 [No Abstract] [Full Text] [Related]
55. Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a case report. Howland RH Can J Psychiatry; 1991 Mar; 36(2):154-5. PubMed ID: 1904303 [No Abstract] [Full Text] [Related]
56. Fluoxetine-induced mania in a patient with obsessive-compulsive disorder. Steiner W Am J Psychiatry; 1991 Oct; 148(10):1403-4. PubMed ID: 1897626 [No Abstract] [Full Text] [Related]
57. Fluoxetine and schizophrenia in a patient with obsessional thinking. Baker RW J Neuropsychiatry Clin Neurosci; 1992; 4(2):232-3. PubMed ID: 1627986 [No Abstract] [Full Text] [Related]
58. Efficacy of trazodone as an anti obsessional agent. Prasad A Pharmacol Biochem Behav; 1985 Feb; 22(2):347-8. PubMed ID: 3983224 [TBL] [Abstract][Full Text] [Related]
59. The use of low-dose neuroleptics in the treatment of "schizo-obsessive" patients. Schulz SC Am J Psychiatry; 1986 Oct; 143(10):1318-9. PubMed ID: 2876650 [No Abstract] [Full Text] [Related]
60. The role of glutamatergic dysfunction in treatment-resistant obsessive-compulsive disorder: treatment of an adolescent case with N-acetylcysteine augmentation. Yazici KU; Percinel I J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):525-7. PubMed ID: 25264963 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]